MarketCap
Facebook
X
Telegram
Cognex Corporation Financial Ratios 2025-2007 | CGNX
Brief overview of Cognex Corporation's financial ratios
Current figures are compared with the company's own five-year history for 2021–2025.
The valuation comparison uses P/E 86.55x (median 55.16x), EV/EBITDA 55.6x (median 45.08x), P/S 9.96x (median 9.61x). The combined ratio level is close to the company's five-year norm at a +3.7% deviation. No clear premium or discount is visible.
The inverse P/E implies an earnings yield of 1.2%. This is not a dividend yield, but current earnings relative to market price.
Capital efficiency is characterized by ROE 7.7%, ROA 5.7%, ROCE 10.9%. Low capital returns limit the ability to compound value internally.
PEG is 12.05x. Price is well ahead of embedded growth, making market expectations demanding.
The cash cycle lengthened by 48.3 days to 168.2 days. Operations require more funding.
Overall picture
Cognex Corporation's valuation and business quality look relatively balanced, with no pronounced distortion in either direction.
Annual Financial Ratios Cognex Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
86.5 | 55.2 | 58.2 | 44.8 | 49.0 | 76.8 | 44.5 | 35.1 | 62.1 | 38.3 | 14.9 | 26.3 | 45.4 | 24.9 | 24.9 | 3.0 | -27.1 | 10.5 | - |
P/S |
10.0 | 6.4 | 7.9 | 9.6 | 13.2 | 16.7 | 12.5 | 9.5 | 14.7 | 11.0 | 6.2 | 6.6 | 9.4 | 5.2 | 5.4 | - | - | - | - |
EPS |
0.7 | 0.6 | 0.7 | 1.2 | 1.6 | 1.0 | 1.2 | 1.3 | 1.0 | 0.8 | 1.1 | 1.4 | 0.8 | 0.8 | 0.8 | 1.5 | -0.1 | 0.7 | - |
EV (Enterprise Value) |
10.2 B | 6.15 B | 6.9 B | 10 B | 14.1 B | 13.8 B | 9.44 B | 7.74 B | 11.1 B | 5.72 B | 2.79 B | 3.22 B | 3.37 B | 1.7 B | 1.76 B | 154 M | 12.1 M | 159 M | -104 M |
EBITDA per Share |
1.09 | 0.8 | 0.86 | 1.51 | 1.88 | 1.11 | 0.978 | 1.41 | 1.59 | 1.03 | 0.786 | 0.899 | 0.561 | 0.55 | 0.568 | 2.14 | -0.05 | 0.72 | - |
EV/EBITDA |
55.6 | 45.1 | 46.6 | 38.1 | 42.1 | 60.3 | 53.2 | 31.3 | 39.4 | 32.1 | 20.1 | 20.1 | 33.9 | 17.5 | 17.9 | 1.8 | -5.8 | 5.3 | - |
PEG |
12.05 | 21.03 | -27.88 | 10.71 | 2.57 | 6.73 | -7.07 | 1.45 | 3.68 | -1.98 | 0.27 | 0.41 | 6.57 | -5.19 | 2.95 | - | - | - | - |
P/B |
6.6 | 3.9 | 4.4 | 6.7 | 9.6 | 10.7 | 6.7 | 6.8 | 10.0 | 5.9 | 3.4 | 4.3 | 5.2 | 3.0 | 3.1 | 0.4 | 0.3 | - | - |
P/CF |
40.3 | 39.3 | 58.3 | 39.7 | 43.7 | 55.8 | 39.2 | 41.3 | 56.3 | 33.8 | 31.0 | 23.6 | 40.7 | 18.6 | 22.2 | 2.4 | 10.7 | 4.9 | - |
ROE % |
7.67 | 7.00 | 7.53 | 14.98 | 19.57 | 13.96 | 15.04 | 19.31 | 16.18 | 15.54 | 22.66 | 16.50 | 11.43 | 11.90 | 12.63 | 12.97 | -1.23 | 6.60 | - |
ROA % |
5.68 | 5.33 | 5.61 | 11.01 | 13.97 | 9.78 | 10.81 | 17.00 | 13.76 | 14.40 | 21.07 | 14.78 | 10.37 | 10.85 | 11.42 | 11.51 | -1.11 | - | - |
ROCE % |
10.90 | 7.58 | 8.69 | 17.12 | 22.03 | 13.51 | 8.08 | 18.45 | 22.07 | 16.53 | 14.58 | 19.39 | 13.31 | 14.44 | 15.30 | 16.00 | -3.21 | 6.08 | - |
Current Ratio |
3.8 | 4.2 | 3.9 | 3.8 | 3.5 | 3.3 | 5.0 | 8.5 | 5.6 | 8.0 | 8.4 | 3.3 | 5.4 | 4.8 | 5.3 | - | - | - | - |
DSO |
53.2 | 51.4 | 52.2 | 46.4 | 45.1 | 51.6 | 54.4 | 57.7 | 61.9 | 40.4 | 34.7 | 38.2 | 54.7 | 47.7 | 54.7 | - | - | - | - |
DIO |
163.9 | 202.2 | 219.9 | 151.3 | 114.5 | 107.1 | 115.9 | 147.5 | 147.0 | 85.2 | 132.9 | 107.2 | 111.5 | 120.2 | 131.6 | 93.0 | 54.5 | - | - |
DPO |
49.0 | 37.6 | 37.5 | 45.7 | 39.7 | 30.2 | 34.4 | 28.7 | 50.8 | 31.0 | 28.0 | 57.6 | 41.2 | 31.3 | 33.2 | 28.5 | 16.1 | - | - |
Operating Cycle |
217.1 | 253.5 | 272.1 | 197.7 | 159.5 | 158.6 | 170.4 | 205.2 | 208.9 | 125.6 | 167.6 | 145.4 | 166.2 | 167.9 | 186.3 | 93.0 | 54.5 | - | - |
Cash Conversion Cycle |
168.2 | 215.9 | 234.6 | 152.0 | 119.8 | 128.4 | 136.0 | 176.5 | 158.1 | 94.6 | 139.6 | 87.8 | 125.0 | 136.6 | 153.0 | 64.5 | 38.4 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Cognex Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.43 | 0.31 | 0.11 | 0.24 | 0.14 | - | 0.17 | 0.21 | 0.07 | - | 0.11 | 0.33 | 0.15 | - | 0.2 | 0.34 | 0.39 | - | - | - | - | 0.4 | 0.5 | -0.01 | 0.12 | 0.47 | 0.24 | 0.28 | 0.19 | 0.47 | 0.24 | 0.28 | 0.19 | 0.26 | 0.47 | 0.33 | 0.21 | - | 0.63 | 0.5 | 0.18 | - | 1.21 | 0.5 | 0.24 | - | 0.58 | 0.3 | 0.21 | - | 0.24 | 0.19 | 0.18 | - | 0.21 | 0.46 | 0.34 | - | 0.43 | 0.46 | 0.33 | 0.46 | 0.38 |
EBITDA per Share |
0.57 | 0.39 | 0.44 | - | 0.19 | - | - | - | 0.11 | - | - | - | 0.15 | - | 0.3 | 0.38 | 0.52 | - | 0.57 | 0.52 | 0.47 | 0.34 | 0.65 | 0.03 | 0.15 | 0.1 | 0.34 | 0.36 | 0.21 | 0.1 | 0.33 | 0.35 | 0.2 | 0.26 | 0.51 | 0.4 | 0.22 | - | 0.74 | 0.65 | 0.22 | - | 0.41 | 0.65 | 0.28 | - | 0.71 | 0.35 | 0.28 | - | 0.33 | 0.27 | 0.23 | - | 0.31 | 0.62 | 0.45 | - | 0.63 | 0.64 | 0.45 | 0.79 | 0.63 |
ROE % |
11.84 | 9.00 | 7.40 | 8.61 | 6.73 | 5.10 | 6.37 | 8.36 | 7.73 | 6.92 | 9.37 | 12.34 | 13.41 | 11.64 | 16.92 | 19.91 | 20.82 | 15.86 | 21.35 | 23.00 | 17.48 | 13.96 | 14.39 | 10.53 | 14.22 | 15.04 | 16.19 | 16.79 | 17.48 | 17.96 | 15.03 | 18.70 | 19.53 | 20.01 | 21.44 | 18.54 | 14.96 | 11.56 | 24.17 | 23.89 | 21.93 | 20.39 | 27.23 | 18.14 | 15.36 | 12.88 | 16.10 | 11.87 | 10.76 | 8.25 | 11.36 | 11.60 | 11.48 | 9.06 | 12.32 | 12.66 | 11.68 | 9.18 | 13.35 | 13.87 | 2.47 | 4.17 | 3.78 |
ROA % |
8.82 | 6.70 | 5.56 | 6.48 | 5.06 | 3.84 | 4.79 | 6.23 | 5.72 | 5.12 | 6.91 | 9.44 | 10.42 | 9.12 | 12.95 | 11.16 | 14.82 | 11.34 | 15.19 | 16.20 | 12.31 | 9.78 | 10.19 | 7.54 | 10.19 | 10.81 | 12.78 | 13.80 | 15.00 | 15.81 | 13.11 | 16.12 | 16.70 | 17.03 | 18.67 | 16.54 | 13.61 | 10.72 | 22.45 | 22.20 | 20.39 | 18.96 | 25.09 | 16.52 | 13.85 | 11.54 | 14.46 | 10.70 | 9.74 | 7.49 | 10.32 | 10.55 | 10.46 | 8.26 | 11.21 | 11.49 | 10.57 | 8.30 | 11.93 | 12.26 | 2.23 | 3.63 | 3.28 |
ROCE % |
16.06 | 12.61 | 10.58 | 9.26 | 7.33 | 5.52 | 7.58 | 9.97 | 8.95 | 7.99 | 10.87 | 13.50 | 15.48 | 13.95 | 19.81 | 23.41 | 24.50 | 18.12 | 22.80 | 24.60 | 17.63 | 13.51 | 10.13 | 5.65 | 9.95 | 10.52 | 10.77 | 11.39 | 12.13 | 12.56 | 15.14 | 18.45 | 19.68 | 20.18 | 21.72 | 19.77 | 15.68 | 12.52 | 15.97 | 16.58 | 14.10 | 12.40 | 19.91 | 20.00 | 16.77 | 14.10 | 17.73 | 13.34 | 12.60 | 9.56 | 13.37 | 13.82 | 13.78 | 10.99 | 15.04 | 15.58 | 14.64 | 11.54 | 16.65 | 17.48 | 3.14 | 5.12 | 4.87 |
Current Ratio |
4.0 | 3.8 | 3.9 | 4.0 | 4.0 | 4.2 | 4.2 | 4.0 | 3.8 | 3.9 | 4.0 | 3.9 | 3.7 | 3.8 | 3.7 | - | 3.4 | 3.5 | 3.7 | 3.4 | 3.5 | 3.3 | 3.3 | 3.3 | 3.3 | 3.6 | 3.6 | 3.6 | 3.6 | 8.3 | 8.3 | 8.3 | 8.3 | 6.7 | 6.7 | 6.7 | 6.7 | 13.7 | 13.7 | 13.7 | 13.7 | 14.3 | 14.3 | 14.3 | 14.3 | 9.6 | 9.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
60.6 | 55.3 | 55.8 | 63.2 | 64.3 | - | 61.7 | 56.8 | 54.7 | - | 64.4 | 54.9 | 61.1 | - | 21.0 | 25.8 | 46.1 | - | 44.7 | 47.1 | 48.6 | 51.3 | 45.7 | 67.8 | 62.5 | 55.6 | 51.5 | 47.4 | 58.5 | 64.0 | 46.8 | 51.5 | 64.2 | 56.4 | 41.0 | 61.2 | 57.4 | - | 34.2 | 34.4 | 46.6 | - | 36.3 | 27.2 | 37.3 | - | 23.7 | 45.0 | 52.2 | - | 53.3 | 55.9 | 53.8 | - | 48.3 | 45.9 | 53.2 | - | 54.9 | 52.8 | 58.5 | - | - |
DIO |
148.6 | 164.4 | 146.8 | 166.7 | 197.0 | - | 189.3 | 205.9 | 220.7 | - | 217.9 | 184.0 | 198.5 | - | 86.3 | 79.8 | 144.6 | - | 79.7 | 86.6 | 103.2 | - | 92.9 | 110.3 | 134.1 | - | 115.4 | 107.9 | 141.5 | - | 129.1 | 140.3 | 171.6 | - | 91.1 | 147.0 | 133.1 | - | 75.2 | 69.9 | 139.9 | - | 129.4 | 111.7 | 135.9 | - | 70.7 | 162.4 | 132.5 | - | 109.8 | 110.8 | 121.9 | - | 122.5 | 116.3 | 129.9 | - | 135.3 | 132.3 | 129.0 | 106.1 | - |
DPO |
66.5 | 61.8 | 44.7 | 48.1 | 51.8 | - | 31.9 | 31.4 | 32.4 | - | 41.2 | 38.5 | 43.0 | - | 17.7 | 26.1 | 51.4 | - | 31.5 | 35.5 | 31.4 | - | 24.9 | 29.5 | 37.8 | - | 34.2 | 32.0 | 33.6 | - | 25.2 | 27.3 | 45.0 | - | 31.5 | 50.8 | 46.7 | - | 27.4 | 25.5 | 38.5 | - | 27.2 | 23.5 | 51.2 | - | 41.7 | 91.1 | 61.9 | - | 40.5 | 40.9 | 38.3 | - | 31.9 | 30.3 | 33.3 | - | 34.2 | 33.4 | 33.3 | 32.2 | - |
Operating Cycle |
- | - | - | 229.9 | 261.3 | - | 250.9 | 262.7 | 275.4 | - | 282.3 | 238.9 | 259.6 | - | 107.3 | 105.5 | 190.7 | - | 124.3 | 133.7 | 151.8 | 51.3 | 138.6 | 178.1 | 196.6 | 55.6 | 166.9 | 155.3 | 200.1 | 64.0 | 175.9 | 191.8 | 235.8 | 56.4 | 132.0 | 208.2 | 190.5 | - | 109.4 | 104.3 | 186.6 | - | 165.8 | 138.8 | 173.2 | - | 94.4 | 207.4 | 184.7 | - | 163.1 | 166.8 | 175.7 | - | 170.8 | 162.1 | 183.1 | - | 190.2 | 185.1 | - | - | - |
Cash Conversion Cycle |
- | - | - | 181.8 | 209.6 | - | 219.1 | 231.3 | 243.0 | - | 241.1 | 200.4 | 216.7 | - | 89.6 | 79.4 | 139.3 | - | 92.9 | 98.2 | 120.3 | 51.3 | 113.7 | 148.6 | 158.8 | 55.6 | 132.7 | 123.3 | 166.4 | 64.0 | 150.8 | 164.4 | 190.8 | 56.4 | 100.5 | 157.4 | 143.8 | - | 82.0 | 78.8 | 148.1 | - | 138.5 | 115.3 | 122.0 | - | 52.7 | 116.3 | 122.8 | - | 122.6 | 125.8 | 137.4 | - | 138.9 | 131.9 | 149.8 | - | 156.0 | 151.6 | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Cognex Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
China
Niderland
Schweiz
